Case Study

Where Packaging Expertise Meets Operational Excellence

[Packaging Technology Case Sudy]
Advancing Medicine Together through Specialized Packaging Expertise

Challenge

As pharmaceutical companies place greater emphasis on patient-centric therapies, packaging, as an important contributor to the patient experience, has become even more important.

Platform solutions such as Smurfit Westrock’s DosePak® are designed to help improve medication adherence through intuitive dose presentation, while providing additional space for patient education, product information and brand communication. The child-resistant and senior-friendly designs of Dosepak® can be customized to specific blister and product requirements, meeting the needs of a wide range of therapies and patient populations.

Delivering these benefits requires more than an innovative packaging format. The manufacturing & packing of DosePak® solutions demand specialized walleting technology, validated GMP processes and experienced packaging teams capable of consistently delivering quality across both clinical and commercial programs.

The Myonex Solution

For more than 10 years, Myonex has provided in-house DosePak® packaging services for clinical trial sponsors and commercial pharmaceutical companies.

This capability combines:

Dedicated walleting machines
Both thermoformed and more sensitive Alu-Alu blister formats, requiring enhanced care throughout packaging operations
Qualified GMP packaging operations
Experienced packaging, engineering and Quality teams
Robust process controls throughout production
Continuous optimization of manufacturing processes, equipment settings and operational performance

By combining specialized technology with pharmaceutical packaging expertise, Myonex delivers reliable DosePak® packaging solutions tailored to both clinical and commercial requirements.

Results

Proven Packaging Expertise: More than a decade of experience delivering specialized DosePak® packaging operations.

Reliable Operational Execution: Dedicated equipment, standardized processes and experienced teams delivering consistent packaging quality.

Clinical & Commercial Capability: One GMP packaging platform supporting products from clinical development through commercialization.

Continuous Improvement: Ongoing optimization of manufacturing processes and equipment performance to continuously strengthen efficiency, robustness and quality.

Conclusion

The value of patient-centric packaging depends not only on its design, but also on the ability to package pharmaceutical products consistently and to the highest GMP quality standards.

By combining specialized DosePak® packaging capabilities with GMP operational excellence and a continuous improvement mindset, Myonex helps pharmaceutical companies deliver packaging solutions that support both a better patient experience and reliable supply throughout the product lifecycle.

Advancing Medicine Together.